Carlisle Companies (CSL)
(Delayed Data from NYSE)
$417.61 USD
+9.12 (2.23%)
Updated May 9, 2024 04:00 PM ET
After-Market: $417.86 +0.25 (0.06%) 7:58 PM ET
1-Strong Buy of 5 1
D Value C Growth C Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CSL 417.61 +9.12(2.23%)
Will CSL be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for CSL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CSL
ITT Q1 Earnings & Revenues Beat Estimates, Increase Y/Y
3M (MMM) Q1 Earnings & Revenues Surpass Estimates, Up Y/Y
CSL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Carlisle Companies Incorporated (CSL) Hits Fresh High: Is There Still Room to Run?
Other News for CSL
Ligand Reports First Quarter 2024 Financial Results
5 Oppenheimer’s Fundamental Focus Calls
10 Sleep-Well-At-Night Dividend Aristocrats Perfect For Whatever's Coming Next
Recently Published Real-World Evidence Study Shows Effectiveness of Cell-Based Quadrivalent Influenza Vaccine Over Three Seasons
Analysts Offer Insights on Industrial Goods Companies: Carlisle Companies (CSL), Bluelinx Holdings (BXC) and Upwork (UPWK)